1 Glucagon Like Peptide 2 Receptor Market Overview 1.1 Product Overview and Scope of Glucagon Like Peptide 2 Receptor 1.2 Glucagon Like Peptide 2 Receptor Segment by Type 1.2.1 Global Glucagon Like Peptide 2 Receptor Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 FE-203799 1.2.3 Glepaglutide 1.2.4 GXG-8 1.2.5 HM-15910 1.2.6 Others 1.3 Glucagon Like Peptide 2 Receptor Segment by Application 1.3.1 Glucagon Like Peptide 2 Receptor Sales Comparison by Application: (2021-2027) 1.3.2 Short Bowel Syndrome 1.3.3 Diabetes 1.3.4 Diarrhea 1.3.5 Obesity 1.3.6 Others 1.4 Global Glucagon Like Peptide 2 Receptor Market Size Estimates and Forecasts 1.4.1 Global Glucagon Like Peptide 2 Receptor Revenue 2016-2027 1.4.2 Global Glucagon Like Peptide 2 Receptor Sales 2016-2027 1.4.3 Glucagon Like Peptide 2 Receptor Market Size by Region: 2016 Versus 2021 Versus 2027 2 Glucagon Like Peptide 2 Receptor Market Competition by Manufacturers 2.1 Global Glucagon Like Peptide 2 Receptor Sales Market Share by Manufacturers (2016-2021) 2.2 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Glucagon Like Peptide 2 Receptor Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Glucagon Like Peptide 2 Receptor Manufacturing Sites, Area Served, Product Type 2.5 Glucagon Like Peptide 2 Receptor Market Competitive Situation and Trends 2.5.1 Glucagon Like Peptide 2 Receptor Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Glucagon Like Peptide 2 Receptor Players Market Share by Revenue 2.5.3 Global Glucagon Like Peptide 2 Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Glucagon Like Peptide 2 Receptor Retrospective Market Scenario by Region 3.1 Global Glucagon Like Peptide 2 Receptor Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Glucagon Like Peptide 2 Receptor Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country 3.3.1 North America Glucagon Like Peptide 2 Receptor Sales by Country 3.3.2 North America Glucagon Like Peptide 2 Receptor Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country 3.4.1 Europe Glucagon Like Peptide 2 Receptor Sales by Country 3.4.2 Europe Glucagon Like Peptide 2 Receptor Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Glucagon Like Peptide 2 Receptor Market Facts & Figures by Region 3.5.1 Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Region 3.5.2 Asia Pacific Glucagon Like Peptide 2 Receptor Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country 3.6.1 Latin America Glucagon Like Peptide 2 Receptor Sales by Country 3.6.2 Latin America Glucagon Like Peptide 2 Receptor Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Glucagon Like Peptide 2 Receptor Market Facts & Figures by Country 3.7.1 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country 3.7.2 Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Glucagon Like Peptide 2 Receptor Historic Market Analysis by Type 4.1 Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2016-2021) 4.2 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2016-2021) 4.3 Global Glucagon Like Peptide 2 Receptor Price by Type (2016-2021) 5 Global Glucagon Like Peptide 2 Receptor Historic Market Analysis by Application 5.1 Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2016-2021) 5.2 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2016-2021) 5.3 Global Glucagon Like Peptide 2 Receptor Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Hanmi Pharmaceuticals Co Ltd 6.1.1 Hanmi Pharmaceuticals Co Ltd Corporation Information 6.1.2 Hanmi Pharmaceuticals Co Ltd Description and Business Overview 6.1.3 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Hanmi Pharmaceuticals Co Ltd Product Portfolio 6.1.5 Hanmi Pharmaceuticals Co Ltd Recent Developments/Updates 6.2 Naia Ltd 6.2.1 Naia Ltd Corporation Information 6.2.2 Naia Ltd Description and Business Overview 6.2.3 Naia Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Naia Ltd Product Portfolio 6.2.5 Naia Ltd Recent Developments/Updates 6.3 Takeda 6.3.1 Takeda Corporation Information 6.3.2 Takeda Description and Business Overview 6.3.3 Takeda Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Takeda Product Portfolio 6.3.5 Takeda Recent Developments/Updates 6.4 Tasly Pharmaceutical Group Co Ltd 6.4.1 Tasly Pharmaceutical Group Co Ltd Corporation Information 6.4.2 Tasly Pharmaceutical Group Co Ltd Description and Business Overview 6.4.3 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Tasly Pharmaceutical Group Co Ltd Product Portfolio 6.4.5 Tasly Pharmaceutical Group Co Ltd Recent Developments/Updates 6.5 Zealand Pharma AS 6.5.1 Zealand Pharma AS Corporation Information 6.5.2 Zealand Pharma AS Description and Business Overview 6.5.3 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Zealand Pharma AS Product Portfolio 6.5.5 Zealand Pharma AS Recent Developments/Updates 7 Glucagon Like Peptide 2 Receptor Manufacturing Cost Analysis 7.1 Glucagon Like Peptide 2 Receptor Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Glucagon Like Peptide 2 Receptor 7.4 Glucagon Like Peptide 2 Receptor Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Glucagon Like Peptide 2 Receptor Distributors List 8.3 Glucagon Like Peptide 2 Receptor Customers 9 Glucagon Like Peptide 2 Receptor Market Dynamics 9.1 Glucagon Like Peptide 2 Receptor Industry Trends 9.2 Glucagon Like Peptide 2 Receptor Growth Drivers 9.3 Glucagon Like Peptide 2 Receptor Market Challenges 9.4 Glucagon Like Peptide 2 Receptor Market Restraints 10 Global Market Forecast 10.1 Glucagon Like Peptide 2 Receptor Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Glucagon Like Peptide 2 Receptor by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Glucagon Like Peptide 2 Receptor by Type (2022-2027) 10.2 Glucagon Like Peptide 2 Receptor Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Glucagon Like Peptide 2 Receptor by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Glucagon Like Peptide 2 Receptor by Application (2022-2027) 10.3 Glucagon Like Peptide 2 Receptor Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Glucagon Like Peptide 2 Receptor by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Glucagon Like Peptide 2 Receptor by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs) Growth Rate Comparison by Type (2021-2027) Table 2. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs) Comparison by Application (2021-2027) Table 3. Global Glucagon Like Peptide 2 Receptor Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Glucagon Like Peptide 2 Receptor Covered in This Study Table 5. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs) of Key Manufacturers (2016-2021) Table 6. Global Glucagon Like Peptide 2 Receptor Sales Share by Manufacturers (2016-2021) Table 7. Global Glucagon Like Peptide 2 Receptor Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Glucagon Like Peptide 2 Receptor Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Glucagon Like Peptide 2 Receptor Average Price (USD/Pcs) of Key Manufacturers (2016-2021) Table 10. Manufacturers Glucagon Like Peptide 2 Receptor Manufacturing Sites and Area Served Table 11. Manufacturers Glucagon Like Peptide 2 Receptor Product Type Table 12. Global Glucagon Like Peptide 2 Receptor Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Glucagon Like Peptide 2 Receptor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon Like Peptide 2 Receptor as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Glucagon Like Peptide 2 Receptor Sales by Region (2016-2021) & (K Pcs) Table 16. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2016-2021) Table 17. Global Glucagon Like Peptide 2 Receptor Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Glucagon Like Peptide 2 Receptor Sales by Country (2016-2021) & (K Pcs) Table 19. North America Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2016-2021) Table 20. North America Glucagon Like Peptide 2 Receptor Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2016-2021) Table 22. Europe Glucagon Like Peptide 2 Receptor Sales by Country (2016-2021) & (K Pcs) Table 23. Europe Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2016-2021) Table 24. Europe Glucagon Like Peptide 2 Receptor Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Region (2016-2021) & (K Pcs) Table 27. Asia Pacific Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2016-2021) Table 30. Latin America Glucagon Like Peptide 2 Receptor Sales by Country (2016-2021) & (K Pcs) Table 31. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2016-2021) Table 32. Latin America Glucagon Like Peptide 2 Receptor Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2016-2021) & (K Pcs) Table 35. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2016-2021) Table 38. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Type (2016-2021) Table 39. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2016-2021) Table 40. Global Glucagon Like Peptide 2 Receptor Revenue (Million US$) by Type (2016-2021) Table 41. Global Glucagon Like Peptide 2 Receptor Revenue Share by Type (2016-2021) Table 42. Global Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Type (2016-2021) Table 43. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Application (2016-2021) Table 44. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2016-2021) Table 45. Global Glucagon Like Peptide 2 Receptor Revenue (Million US$) by Application (2016-2021) Table 46. Global Glucagon Like Peptide 2 Receptor Revenue Share by Application (2016-2021) Table 47. Global Glucagon Like Peptide 2 Receptor Price (USD/Pcs) by Application (2016-2021) Table 48. Hanmi Pharmaceuticals Co Ltd Corporation Information Table 49. Hanmi Pharmaceuticals Co Ltd Description and Business Overview Table 50. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 51. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product Table 52. Hanmi Pharmaceuticals Co Ltd Recent Developments/Updates Table 53. Naia Ltd Corporation Information Table 54. Naia Ltd Description and Business Overview Table 55. Naia Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 56. Naia Ltd Glucagon Like Peptide 2 Receptor Product Table 57. Naia Ltd Recent Developments/Updates Table 58. Takeda Corporation Information Table 59. Takeda Description and Business Overview Table 60. Takeda Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 61. Takeda Glucagon Like Peptide 2 Receptor Product Table 62. Takeda Recent Developments/Updates Table 63. Tasly Pharmaceutical Group Co Ltd Corporation Information Table 64. Tasly Pharmaceutical Group Co Ltd Description and Business Overview Table 65. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 66. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product Table 67. Tasly Pharmaceutical Group Co Ltd Recent Developments/Updates Table 68. Zealand Pharma AS Corporation Information Table 69. Zealand Pharma AS Description and Business Overview Table 70. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 71. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product Table 72. Zealand Pharma AS Recent Developments/Updates Table 73. Production Base and Market Concentration Rate of Raw Material Table 74. Key Suppliers of Raw Materials Table 75. Glucagon Like Peptide 2 Receptor Distributors List Table 76. Glucagon Like Peptide 2 Receptor Customers List Table 77. Glucagon Like Peptide 2 Receptor Market Trends Table 78. Glucagon Like Peptide 2 Receptor Growth Drivers Table 79. Glucagon Like Peptide 2 Receptor Market Restraints Table 80. Global Glucagon Like Peptide 2 Receptor Sales Forecast by Type (2022-2027) & (K Pcs) Table 81. Global Glucagon Like Peptide 2 Receptor Sales Market Share Forecast by Type (2022-2027) Table 82. Global Glucagon Like Peptide 2 Receptor Revenue Forecast by Type (2022-2027) & (US$ Million) Table 83. Global Glucagon Like Peptide 2 Receptor Revenue Market Share Forecast by Type (2022-2027) Table 84. Global Glucagon Like Peptide 2 Receptor Sales Forecast by Application (2022-2027) & (K Pcs) Table 85. Global Glucagon Like Peptide 2 Receptor Sales Market Share Forecast by Application (2022-2027) Table 86. Global Glucagon Like Peptide 2 Receptor Revenue Forecast by Application (2022-2027) & (US$ Million) Table 87. Global Glucagon Like Peptide 2 Receptor Revenue Market Share Forecast by Application (2022-2027) Table 88. Global Glucagon Like Peptide 2 Receptor Sales Forecast by Region (2022-2027) & (K Pcs) Table 89. Global Glucagon Like Peptide 2 Receptor Sales Market Share Forecast by Region (2022-2027) Table 90. Global Glucagon Like Peptide 2 Receptor Revenue Forecast by Region (2022-2027) & (US$ Million) Table 91. Global Glucagon Like Peptide 2 Receptor Revenue Market Share Forecast by Region (2022-2027) Table 92. Research Programs/Design for This Report Table 93. Key Data Information from Secondary Sources Table 94. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Glucagon Like Peptide 2 Receptor Figure 2. Global Glucagon Like Peptide 2 Receptor Market Share by Type in 2020 & 2027 Figure 3. FE-203799 Product Picture Figure 4. Glepaglutide Product Picture Figure 5. GXG-8 Product Picture Figure 6. HM-15910 Product Picture Figure 7. Others Product Picture Figure 8. Global Glucagon Like Peptide 2 Receptor Market Share by Application in 2020 & 2027 Figure 9. Short Bowel Syndrome Figure 10. Diabetes Figure 11. Diarrhea Figure 12. Obesity Figure 13. Others Figure 14. Global Glucagon Like Peptide 2 Receptor Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Glucagon Like Peptide 2 Receptor Market Size 2016-2027 (US$ Million) Figure 16. Global Glucagon Like Peptide 2 Receptor Sales 2016-2027 (K Pcs) Figure 17. Global Glucagon Like Peptide 2 Receptor Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 18. Glucagon Like Peptide 2 Receptor Sales Share by Manufacturers in 2020 Figure 19. Global Glucagon Like Peptide 2 Receptor Revenue Share by Manufacturers in 2020 Figure 20. The Global 5 and 10 Largest Glucagon Like Peptide 2 Receptor Players: Market Share by Revenue in 2020 Figure 21. Glucagon Like Peptide 2 Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 22. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2016-2021) Figure 23. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region in 2020 Figure 24. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2016-2021) Figure 25. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region in 2020 Figure 26. U.S. Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Canada Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Germany Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. France Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. U.K. Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Italy Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Russia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. China Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Japan Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. South Korea Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. India Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Australia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Taiwan Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Indonesia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Thailand Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Malaysia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Philippines Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Vietnam Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Mexico Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Brazil Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Argentina Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Turkey Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Saudi Arabia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. U.A.E Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. Sales Market Share of Glucagon Like Peptide 2 Receptor by Type (2016-2021) Figure 51. Sales Market Share of Glucagon Like Peptide 2 Receptor by Application (2016-2021) Figure 52. Sales Market Share of Glucagon Like Peptide 2 Receptor by Application in 2020 Figure 53. Revenue Share of Glucagon Like Peptide 2 Receptor by Application (2016-2021) Figure 54. Revenue Share of Glucagon Like Peptide 2 Receptor by Application in 2020 Figure 55. Manufacturing Cost Structure of Glucagon Like Peptide 2 Receptor Figure 56. Manufacturing Process Analysis of Glucagon Like Peptide 2 Receptor Figure 57. Glucagon Like Peptide 2 Receptor Industrial Chain Analysis Figure 58. Channels of Distribution Figure 59. Distributors Profiles Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

Hanmi Pharmaceuticals Co Ltd Naia Ltd Takeda Tasly Pharmaceutical Group Co Ltd Zealand Pharma AS